MEDI MYANMAR GROUP LTD — Extract Importer Profile
Pharmaceutical Importer · #2 buyer for Extract · $621.1K import value · 14 shipments · MYANMAR · DGFT Verified
MEDI MYANMAR GROUP LTD is the #2 importer of Extract from India with $621.1K in import value and 14 verified shipments. MEDI MYANMAR GROUP LTD holds a 5.8% market share in Extract imports based in MYANMAR. The company sources from 1 verified supplier across 4 formulations shipped to 1 country.
MEDI MYANMAR GROUP LTD — Extract Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Extract to MEDI MYANMAR GROUP LTD?
Verified from 14 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| TORRENT PHARMACEUTICALS LIMITED | $621.1K | 14 | 100.0% |
MEDI MYANMAR GROUP LTD sources Extract from 1 verified Indian supplier based on 14 customs records. The primary supplier is TORRENT PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
How Does MEDI MYANMAR GROUP LTD Compare to Nearest Extract Importers?
Buyers ranked immediately above and below #2 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | REGENCY PHARMA LIMITED | MAURITIUS | $806.6K | 220 | $3.7K |
| 2 | MEDI MYANMAR GROUP LTD ★ | MYANMAR | $550.0K | 11 | $50.0K |
| 3 | UNAHCO INC | PHILIPPINES | $500.0K | 10 | $50.0K |
| 4 | INOVA PHARMACEUTICALS(SINGAPORE) PT | SINGAPORE | $402.1K | 44 | $9.1K |
MEDI MYANMAR GROUP LTD ranks #2 among 591 Extract importers from India. Average shipment value of $50.0K compared to the market average of $7.3K. The closest competitors by value are REGENCY PHARMA LIMITED and UNAHCO INC.
Where Does MEDI MYANMAR GROUP LTD Import Extract To?
Destination countries from 14 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| MYANMAR | $621.1K | 14 | 100.0% |
MEDI MYANMAR GROUP LTD imports Extract to 1 country. The primary destination is MYANMAR receiving 100.0% of shipments worth $621.1K.
What Extract Formulations Does MEDI MYANMAR GROUP LTD Import?
| Formulation | Value | Shipments |
|---|---|---|
| ENZYSTAL TABLET(PANCREATIN 192MG+EXTRACT | $363.1K | 8 |
| ENZYSTAL TABLET PANCREATIN 192MG EXTRACTFELLIS BOVIS25MG HEMICELLULASE 50MG NOS 10X10 TAB | $172.5K | 4 |
| ENZYSTAL TABLET PANCREATIN 192MG EXTRACT FELLISBOVIS25MG HEMICELLULASE 50MG 10X10 TAB BNO CPE2L005 CPE2L006 CPE2L007 | $50.0K | 1 |
| ENZYSTAL TABLET PANCREATIN 192MG EXTRACT FELLISBOVIS25MG HEMICELLULASE 50MG 10X10 TAB BNO CPE2L008 6768 PACKS | $35.5K | 1 |
MEDI MYANMAR GROUP LTD imports 4 distinct Extract formulations from India. The top formulation is ENZYSTAL TABLET(PANCREATIN 192MG+EXTRACT with 8 shipments worth $363.1K.
Who Are the Top Buyers of Extract from India and How Much Does MEDI MYANMAR GROUP LTD Import?
India exported $4.3M worth of Extract through 2,147 shipments from 292 suppliers to 109 countries, serving 591 buyers globally. MEDI MYANMAR GROUP LTD imports $621.1K of this total, accounting for 5.8% of India's Extract exports with 14 shipments from MYANMAR. This is verified from 14 customs shipment records covering 4 distinct formulations.
What Is the Average Order Value for MEDI MYANMAR GROUP LTD's Extract Imports?
MEDI MYANMAR GROUP LTD's average Extract order value is $44.4K per consignment, based on 14 shipments totaling $621.1K. MEDI MYANMAR GROUP LTD is based in MYANMAR and ranks #2 among all Extract importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Extract to MEDI MYANMAR GROUP LTD?
MEDI MYANMAR GROUP LTD sources Extract from 1 verified Indian supplier: TORRENT PHARMACEUTICALS LIMITED ($621.1K, 100.0%). This is based on 14 customs records.
How Does MEDI MYANMAR GROUP LTD Compare to Other Extract Importers?
MEDI MYANMAR GROUP LTD ranks #2 among 591 Extract importers from India with a 5.8% market share. The top 3 importers are REGENCY PHARMA LIMITED ($806.6K), MEDI MYANMAR GROUP LTD ($550.0K), UNAHCO INC ($500.0K). MEDI MYANMAR GROUP LTD processed 14 shipments from MYANMAR.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Extract — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Extract shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: MEDI MYANMAR GROUP LTD matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as MEDI MYANMAR GROUP LTD's capped import value divided by total capped export value for Extract across all Indian exporters.
- 5.Verified Records: This page is backed by 14 individual customs records matching MEDI MYANMAR GROUP LTD importing Extract, covering 4 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 109+ countries, 591+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Extract Import Data for MEDI MYANMAR GROUP LTD
Access order-level details, pricing data, supplier connections, and competitive analysis for MEDI MYANMAR GROUP LTD's Extract imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MEDI MYANMAR GROUP LTD
Company Profile
Multiple products · $0 total trade · Multiple categories
MEDI MYANMAR GROUP LTD × Extract
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for MEDI MYANMAR GROUP LTD.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Extract. For current order-level data, contact TransData Nexus.